Abstract
Cryptococcosis caused by the fungus Cryptococcus neoformans is an opportunistic mycosis, infecting mainly immunodepressed individuals. Molecular epidemiology studies of cryptococcosis in Europe are limited. This paper presents a retrospective study of cryptococcosis in 105 cryptococcal isolates from two hospitals in Lisbon, Portugal, among HIV/AIDS patients, from 1991 to 2007. Among these patients, the number of cases of cryptococcosis increased from 5.1 to 6.9 cases per year from the pre- to post-highly active antiretroviral therapy (HAART) era. As expected, the median age of the patients increased, from 32 (mean: 33 ± 8) to 39 (mean: 41 ± 10) years, and the ratio of male to female patients remained high (7.7 and 7.6, respectively). Strain genotyping based on restriction fragment length polymorphism of the orotidine monophosphate pyrophosphorylase (URA5-RFLP) gene showed that, in general, the relative frequencies of the genotypes VNI-IV are similar to those from other European countries. These frequencies were, respectively, for the pre- and post-HAART periods: 41.7 and 43.5 % for VNI; 2.8 and 17.4 % for VNII; 38.9 and 30.4 % for VNIII; 16.7 and 7.2 % for VNIV and 0 and 1.4 % for VGII. Some apparent although statistically insignificant differences among these values were observed between both periods. The genotypic frequencies were not also statistically different according to the patients’ gender or age range. Of note are the high proportion of VNIII isolates (common in Europe) and the high increase in the frequency of the VNII genotype in the post-HAART. Ultimately, these results may have implications in disease therapy, management and control.
Similar content being viewed by others
References
Antinori S, Ridolfo AL, Fasan M, Magni C, Galimberti L, Milazzo L, Sollima S, Adorni F, Giuliani G, Galli M, Corbellino M, Parravicini C (2009) AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy. HIV Med 10:6–11
Boekhout T, Theelen B, Diaz M, Fell JW, Hop WC, Abeln EC, Dromer F, Meyer W (2001) Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology 147:891–907
Byrnes EJ III, Bartlett KH, Perfect JR, Heitman J (2011) Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect 13:895–907
Chaturvedi V, Chaturvedi S (2011) Cryptococcus gattii: a resurgent fungal pathogen. Trends Microbiol 19:564–571
Chong HS, Dagg R, Malik R, Chen S, Carter D (2010) In vitro susceptibility of the yeast pathogen Cryptococcus to fluconazole and other azoles varies with molecular genotype. J Clin Microbiol 48:4115–4120
Chowdhary A, Randhawa HS, Boekhout T, Hagen F, Klaassen CH, Meis JF (2012) Temperate climate niche for Cryptococcus gattii in Northern Europe. Emerg Infect Dis 18:172–174
Cogliati M (2013) Global molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii: an atlas of the molecular types. Scientifica 2013:Article ID:675213
Cogliati M, Zamfitova RR, Tortorano AM, Viviani MA, Fimua Cryptococcosis Network (2013) Molecular epidemiology of Italian clinical Cryptococcus neoformans var. grubii isolates. Med Mycol 51:499–506
Colom MF, Hagen F, Gonzalez A, Mellado A, Morera N, Linares C, García DF, Peñataro JS, Boekhout T, Sánchez M (2012) Ceratonia síliqua (carob) trees as natural habitat and source of infection by Cryptococcus gattii in the Mediterranean environment. Med Mycol 50:67–73
Dromer F, Mathoulin-Pélissier S, Fontanet A, Ronin O, Dupont B, Lortholary O, French Cryptococcosis Study Group (2004) Epidemiology of HIV-associated cryptococcosis in France (1985–2001): comparison of the pre- and post-HAART eras. AIDS 18:555–562
Faria NCG (2007) Use of natural products to enhance activity of antifungal drugs. Master thesis, Universidade Nova de Lisboa, Portugal
Ferreira-Paim K, Andrade-Silva L, Mora DJ, Pedrosa AL, Rodrigues V, Silva-Vergara ML (2011) Genotyping of Cryptococcus neoformans isolated from captive birds in Uberaba, Minas Gerais, Brazil. Mycoses 54:e294–e300
Firacative C, Trilles L, Meyer W (2012) MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex. PLoS One 7:e37566
Franzot SP, Hamdan JS, Currie BP, Casadevall A (1997) Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure. J Clin Microbiol 35:2243–2251
Frasés S, Ferrer C, Sánchez M, Colom-Valiente MF (2009) Molecular epidemiology of isolates of the Cryptococcus neoformans species complex from Spain. Rev Iberoam Micol 26:112–117
Gillece JD, Schupp JM, Balajee SA, Harris J, Pearson T, Yan Y, Keim P, DeBess E, Marsden-Haug N, Wohrle R, Engelthaler DM, Lockhart SR (2011) Whole genome sequence analysis of Cryptococcus gattii from the Pacific Northwest reveals unexpected diversity. PLoS One 6:e28550
Hagen F, Khayhan K, Theelen B, Kolecka A, Polacheck I, Sionov E, Falk R, Parnmen S, Lumbsch HT, Boekhout T (2015) Recognition of seven species in Cryptococcus gattii/Cryptococcus neoformans species complex. Fungal Genet Evol 78:16–48
Horta JA, Staats CC, Casali AK, Ribeiro AM, Schrank IS, Schrank A, Vainstein MH (2002) Epidemiological aspects of clinical and environmental Cryptococcus neoformans isolates in the Brazilian state Rio Grande do Sul. Med Mycol 40:565–571
Litvintseva AP, Thakur R, Vilgalys R, Mitchell TG (2006) Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana. Genetics 172:2223–2228
Lucas S, Martins ML, Flores O, Meyer W, Spencer-Martins I, Inácio J (2010) Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification. Clin Microbiol Infect 16:711–714
Maduro AP, Mansinho K, Teles F, Silva I, Meyer W, Martins ML, Inácio J (2014) Insights on the genotype distribution among Cryptococcus neoformans and C. gattii Portuguese clinical isolates. Curr Microbiol 68:199–203
Martins ML (2001) Phenetic polymorphisms and molecular diagnosis of Cryptococcus neoformans. Doctoral thesis, Universidade Nova de Lisboa, Portugal
McClelland EE, Hobbs LM, Rivera J, Casadevall A, Potts WK, Smith JM, Ory JJ (2013) The role of host gender in the pathogenesis of Cryptococcus neoformans infections. PLoS One 8:e63632
Meyer W, Aanensen DM, Boekhout T, Cogliati M, Diaz MR, Esposto MC, Fisher M, Gilgado F, Hagen F, Kaocharoen S, Litvintseva AP, Mitchell TG, Simwami SP, Trilles L, Viviani MA, Kwon-Chung J (2009) Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 47:561–570
Meyer W, Castañeda A, Jackson S, Huynh M, Castañeda E, The IberoAmerican Cryptococcal Study Group (2003) Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 9:189–195
Meyer W, Marszewska K, Amirmostofian M, Igreja RP, Hardtke C, Methling K, Viviani MA, Chindamporn A, Sukroongreung S, John MA, Ellis DH, Sorrell TC (1999) Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by PCR-fingerprinting and RAPD—a pilot study to standardize techniques on which to base a detailed epidemiological survey. Electrophoresis 20:1790–1799
Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d’Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren J (1998) Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 352:1725–1730
Ngamskulrungroj P, Gilgado F, Faganello J, Litvintseva AP, Leal AL, Tsui KM, Mitchell TG, Vainstein MH, Meyer W (2009) Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties. PLoS One 4:e5862
Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525–530
Perea S, Patterson TF (2002) Antifungal resistance in pathogenic fungi. Clin Infect Dis 35:1073–1080
Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Doern GV, Diekema DJ (2005) Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J Clin Microbiol 43:2163–2167
Sabat AJ, Budimir A, Nashev D, Sá-Leão R, van Dijl JM, Laurent F, Grundmann H, Friedrich AW, ESCMID Study Group of Epidemiological Markers (ESGEM) (2013) Overview of molecular typing methods for outbreak detection and epidemiological surveillance. Eurosurveillance 18:20380
Silva IFHPL (2010) Molecular typing of clinical and environmental isolates of Cryptococcus neoformans. Master thesis, Universidade Nova de Lisboa, Portugal
Tanaka K, Miyazaki T, Maesaki S, Mitsutake K, Kakeya H, Yamamoto Y, Yanagihara K, Hossain MA, Tashiro T, Kohno S (1996) Detection of Cryptococcus neoformans genes in patients with pulmonary cryptococcosis. J Clin Microbiol 34:2826–2828
Viviani MA, Cogliati M, Esposto MC, Lemmer K, Tintelnot K, Colom Valiente MF, Swinne D, Velegraki A, Velho R, European Confederation of Medical Mycology (ECMM) Cryptococcosis Working Group (2006) Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe. FEMS Yeast Res 6:614–619
Wiesner DL, Moskalenko O, Corcoran JM, McDonald T, Rolfes MA, Meya DB, Kajumbula H, Kambugu A, Bohjanen PR, Knight JF, Boulware, Nielsen K (2012) Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis. mBio. doi:10.1128/mBio.00196-12
Acknowledgments
This work was supported by the Instituto de Higiene e Medicina Tropical (to A.P.M. and M.L.M.) and the Fundação para a Ciência e a Tecnologia (to L.G. (Grant number OE/MAT/UI0006/2014), J.I. and F.R.R.T.), in Portugal. The clinical cryptococcal isolates used in this study were kindly supplied by Drs. Kamal Mansinho, Carlos Araújo, Jaime Nina, José Luís Champalimaud (from the Hospital of Egas Moniz), Lurdes Monteiro and Maria José Salgado (from the Hospital of Santa Maria). We thank Drs. Francisco Antunes (from the Hospital of Santa Maria) and Jaime Nina for information on antifungal drug therapy used for cryptococcosis by the respective hospitals during the studied time period. We also thank Dr. Wieland Meyer, from the University of Sydney (Australia), for providing us the reference strains for the URA5-RFLP molecular types of the C. neoformans/C. gattii species complex.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Maduro, A.P., Gonçalves, L., Inácio, J. et al. HIV/AIDS-Associated Cryptococcosis in Portugal Spanning the Pre- to Post-HAART Era: A Retrospective Assessment at the Genotypic Level Based on URA5-RFLP. Curr Microbiol 71, 449–457 (2015). https://doi.org/10.1007/s00284-015-0873-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00284-015-0873-z